New inhaled COVID-19 vaccine by McMaster enters phase-2 trials in Canada. The vaccine aims to provide stronger, needle-free ...

Vaxxas, a clinical-stage biotechnology company, today announced it has secured a new patent from the United States patent office covering proprietary manufacturing technology for its novel vaccination ...

Vaxxas, a clinical-stage biotechnology company, today announced it has secured a new patent from the United States patent office covering proprietary manufacturing technology for its novel ...

Since the onset of the COVID-19 pandemic, vaccination rates for both children and adults have declined. Public trust in ...

Researchers are developing vaccines that ditch the needle and lose the side effects while remaining shelf stable. And other vaccines are in the works that could potentially stop a future ...

Researchers at McMaster University have started a phase-2 clinical trial on a next-generation, inhaled COVID-19 vaccine.

Public health physician Dr. Marcy Ahun discusses vaccine delivery innovations, like the auto-disable syringe, that have prevented needle reuse and saved lives in the process.

But some patients are afraid of the needle. Exploring alternative vaccine delivery systems could increase accessibility and encourage those who fear needles to receive necessary healthcare. While ...

Public opinion about vaccines affects furry friends too. We asked veterinarians and other experts to explain the most common misconceptions about animal vaccines.

Researchers at McMaster University have started a phase-2 clinical trial on a next-generation, inhaled COVID-19 vaccine.

Kennedy’s first month in office has been dominated with high-profile resignations, a measles outbreak and — supporters point ...